{"name":"Provectus Biopharmaceuticals, Inc.","slug":"provectus-biopharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":1897276,"netIncome":-5430851,"cash":251291,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2015"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-02","type":"trial","source":"The Manila Times","summary":"Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment - Th","headline":"Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; ","sentiment":"neutral"},{"date":"2026-03-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOU0laOHpxWU1yQlJoQkhIenIwTmZBOGprdGRvc3FWYmpadG4yQ1F5WXJ2M2hXUmtMSFg3ZTN6TjNmTE5JbTcwM2V6Q0VkZmFpd0tmenRTQUh5SmlfaUxROWNvZV9Lb0QzbTFIdUhZYnpyY2Z1elhpTFI1dmxCVjdNRk9RS1J4Qkt2Q0hTdW9vaVFCa2ViX3g3d3hJSlAyTE9ZOENDRDg4bWIzTnFWWVZOb2FKRWl1Vy1QWFJoZDZPZnJ3R3Fz?oc=5","date":"2026-03-20","type":"pipeline","source":"Stock Titan","summary":"PVCT (PVCT) CEO converts 8% note and Series D-1 preferred into common stock - Stock Titan","headline":"PVCT (PVCT) CEO converts 8% note and Series D-1 preferred into common stock","sentiment":"neutral"},{"date":"2026-02-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOVGhBUXB1OTBjUG5kTTdISkxWQWZHQnFISWxYSldGWXNGT1dOM01ZbmRFc2Z3b0prWEVneXItdVdIRkpPQkRUb0o3X0pxek8ycjM3YW5Ob0ZWaHktRDhkTG5HQ2EwU25sRG15aXNOY3lzd2t5TVE1cV9tYXpWUEVpRHo3VldOMWNXTF95dEtweFVycXZZWTV1UWhGay02WXZMRFpCVzYzSkw4aTdBT0NUdmh2VkhnWFduRkNkdHJ6QQ?oc=5","date":"2024-12-11","type":"pipeline","source":"Stock Titan","summary":"Provectus Launches VisiRose: Groundbreaking Eye Infection Treatment Venture with University of Miami - Stock Titan","headline":"Provectus Launches VisiRose: Groundbreaking Eye Infection Treatment Venture with University of Miami","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNSE9KTmpDdC1ObTZpYkI2TUJpNkNITHNUbHJULWx6TEVIdHNQZWlzTUpOa1RjbkMyTGNOYVE3eWZCUU1YSlVIdEVJUGQxd2RZQXA1Vm1DTkhqYXpMTmdhYTUyS3pPY3dGZE9DOUJFM1ExTWRZcGZVTFZxRlgzN3QwVTlMVURaWmhqZm9jRXk2ZzA0aGNnSGpUaFVBRGV4T0oyWUFaOHRPUXVBeEdhLVFLcW4zeUxMLWU1akswTHlNSnpaSHN0ZTVDNVRTdUR3Z0dKY1AxYS0tNTlDZUZHN0F3?oc=5","date":"2024-10-10","type":"earnings","source":"GlobeNewswire","summary":"Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call - GlobeNewswire","headline":"Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOTDJFUEpqQ0dhcUhfUFh0VUpVTU1YZ1cyVXZZX2V5TmFyRmhHUFA0MXhJUFFtazluUjRYTmR6dG5iMk5vSl85VmVvRnVTT0YxQXd0TWlPcnE0bHk3eDhEa2g4Qng0dEJMZDdJU2ltaDBCMlJLdnpXN004RTh2bnJ0cUZEQnNiQ09zVHJqRG9JTTZCZlBhOWlLME9IWXJZNWtlbm9IQzczbGtyR1dDZGgyRXpGOFRibVZPWGp6U2NuMlhKWU51bXpGWEJiYw?oc=5","date":"2024-05-20","type":"pipeline","source":"Knoxville News Sentinel","summary":"'Called to shepherd': PYA's Ed Pershing gets second career as Provectus CEO - Knoxville News Sentinel","headline":"'Called to shepherd': PYA's Ed Pershing gets second career as Provectus CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPN3NybmdUUFI0NHc2SFJhZTM5OERGTVhXSUkzbm1vRGNsYVNvcDJObUFYbHBDNW1jTjl6Vy0tNGFqRW1VSmNNdlhKOWN0eXhxMk1Pa18wY0VjdVlKNXVicHFfZnE2X1h3MXpSZkdkbk5LTTA0RWNra0NkWjlqQlliak1xeHZ5U3B0NkJkdU1PeGlhY1N6UUZOZ0tNTmwzdTNYTVVoQXlUN0Z0VVBjQnpqd3lFY1BYOHRJNWc?oc=5","date":"2017-12-29","type":"pipeline","source":"Knoxville News Sentinel","summary":"SEC: Provectus money went to Hooters, not cancer drugs - Knoxville News Sentinel","headline":"SEC: Provectus money went to Hooters, not cancer drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNQl85OTNIZTRVdF9zQUtjazZlaDkxenExdC1zWWRRSmp2RjVoNzVNdlpzbWFsc2pLQ1d0cmlFTmdmSlREdU53R0tXbTY5RHl4SV83MFdvdVlOMldYbFA2QUJhR3IwcGJKdGlHNXlpLWNxUEI4LXUzeU1TNExYT3doN1pPQzVfTkFsS0pBekhaR2d1dnQ2Zm9rc1Fuem5kN00xRzJ6OC11eUtQS3JrNS1vZXpfeG41aVNuc0toOGxKX1pNb0taTmROLUt3MHFzdw?oc=5","date":"2017-02-24","type":"pipeline","source":"PR Newswire","summary":"Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline - PR Newswire","headline":"Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOdVpKYlRLSVRRWld3aXBRd2JhUC1XbFN3c21QWmx1ZGdHdGRMSVMxZS1wZEZBY01sbmotZkJ6cTdveGpjTU4zM1h2MHhWanRtd2ZkNHFmSGlzT1NDY3pJcXlrczNnMVRKTFl1VUhUdVlsZC1KbjdMcE8za2tYV1k2ZXB0ZDctZ0IxQTdXZ0ZSaHZYYlBxT3VKS0w1NE1oZHBvcmdhX0RRTGo?oc=5","date":"2016-03-01","type":"patent","source":"Knoxville News Sentinel","summary":"provectus-gets-patent-extension-for-cancer-drug - Knoxville News Sentinel","headline":"provectus-gets-patent-extension-for-cancer-drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2015-12-31","revenueHistory":[{"value":0,"period":"2015-12-31"},{"value":0,"period":"2014-12-31"},{"value":0,"period":"2013-12-31"},{"value":0,"period":"2012-12-31"}],"grossProfit":24541,"grossProfitHistory":[],"rdSpend":1897276,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5430851,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":251291,"cashHistory":[],"totalAssets":697502,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}